
Sign up to save your podcasts
Or
In this episode of Health in Hyperdrive, host Dominic James is joined by Alex Sheppard to explore how academic research evolves from campus curiosity into commercial impact, ultimately helping us live longer, healthier lives.
Healthcare has always been grounded in science, and its deep ties to academia are more relevant than ever. From the rapid development of COVID-19 vaccines, accelerated by breakthroughs at MIT and the University of Mainz, to the rise of billion-dollar AI health companies born from university labs, the journey from research to reality is accelerating.
Alex brings a rare insider’s perspective, having led an Oxford University HealthTech spinout and now working across startups, investment, and industry. Together, they unpack the mechanics of academic spinouts, the role of multidisciplinary expertise, and how AI is reshaping empathy, equity, and access in healthcare. From digital scribing to orbital health stations, this episode charts a bold vision for health in 2050 and beyond.
Key Topics Covered
About Alex
Start-up co-founder and Investor
Alex Sheppard is a start-up co-founder, investor and industry expert with deep ties to Oxford University’s innovation teams. Formerly the CEO of an Oxford HealthTech spinout, he brings first hand experience in translating academic research into commercial success. Today, Alex works across the health tech landscape to bridge academia, entrepreneurship and industry, driving innovation that is both scientifically rigorous and socially impactful.
About Dom
Dominic brings two decades of experience as a former Global Health Innovation Leader for Merck (top 5 pharma), successful Innovation Consultancy Co-Founder, Management Consulting Partner (Deloitte, Ogilvy, SBC) and Data Scientist. With an extensive network in the US, Europe & Asia, he brings together experts and organizations to work tirelessly deliver our mission of improving health by ten times through new technology.
Links
In this episode of Health in Hyperdrive, host Dominic James is joined by Alex Sheppard to explore how academic research evolves from campus curiosity into commercial impact, ultimately helping us live longer, healthier lives.
Healthcare has always been grounded in science, and its deep ties to academia are more relevant than ever. From the rapid development of COVID-19 vaccines, accelerated by breakthroughs at MIT and the University of Mainz, to the rise of billion-dollar AI health companies born from university labs, the journey from research to reality is accelerating.
Alex brings a rare insider’s perspective, having led an Oxford University HealthTech spinout and now working across startups, investment, and industry. Together, they unpack the mechanics of academic spinouts, the role of multidisciplinary expertise, and how AI is reshaping empathy, equity, and access in healthcare. From digital scribing to orbital health stations, this episode charts a bold vision for health in 2050 and beyond.
Key Topics Covered
About Alex
Start-up co-founder and Investor
Alex Sheppard is a start-up co-founder, investor and industry expert with deep ties to Oxford University’s innovation teams. Formerly the CEO of an Oxford HealthTech spinout, he brings first hand experience in translating academic research into commercial success. Today, Alex works across the health tech landscape to bridge academia, entrepreneurship and industry, driving innovation that is both scientifically rigorous and socially impactful.
About Dom
Dominic brings two decades of experience as a former Global Health Innovation Leader for Merck (top 5 pharma), successful Innovation Consultancy Co-Founder, Management Consulting Partner (Deloitte, Ogilvy, SBC) and Data Scientist. With an extensive network in the US, Europe & Asia, he brings together experts and organizations to work tirelessly deliver our mission of improving health by ten times through new technology.
Links